Global Hemodialysis Concentrates Market By Type (Acid Concentrates, And Bicarbonate Concentrates), By Application (Dialysis Center, And Home), By Region And Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends And Forecast 2021-2030 (Includes Business Impact of COVID-19)

                                          
Report updated on 11th September, 2021: Global Hemodialysis Concentrates Market By Type (Acid Concentrates, And Bicarbonate Concentrates), By Application (Dialysis Center, And Home), By Region And Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends And Forecast 2021-2030 (Includes Business Impact of COVID-19)
Trusted Business Insights has published a comprehensive market research report on, Global Hemodialysis Concentrates Market by Product Type (Acid Concentrates, Bicarbonate Concentrates), By Application(Dialysis Centre, Home), and by Region -Global Forecast to 2030, which offers a holistic view of the global hemodialysis concentrates market through systematic segmentation that covers every aspect of the target market.

The global hemodialysis concentrates market is projected to be US$ 2402.6 Mn in 2020 to reach US$ 3653.1 Mn by 2030 at a CAGR of 4.4%.

Hemodialysis is a medical process that filters waste material and removes extra fluids from blood to correct the electrolyte imbalances of the body. Hemodialysis is one of the renal replacement therapy, carried out with the help of a dialysis machine, that tracks the blood flow, blood pressure and other vital activities. The machine mixes dialysate or dialysis solution that goes into the dialyzer, and the fluid helps to remove toxins from the blood. Dialysate or dialysis solution is made up of acid and bicarbonate concentrates. An acidified concentrated mixture of salts and concentrated preparation of sodium bicarbonate are diluted with dialysis water; this produced dialysis fluid is used in dialysis treatment. The dialysate mixes with the blood, it is highly important that these solutions are contaminant-free, since any type of contamination in the blood may result in severe ailments for the patient. Care also needs to be taken that the dialysate is not excessively concentrated or diluted since both situations can cause grave harm to the patient.

An increasing number of renal diseases- the rising prevalence of kidney-related diseases among the population including diabetes, hypertension, etc. is a key factor likely to increase adoption of hemodialysis treatment, thereby fueling the growth of hemodialysis concentrates market.


Global Hemodialysis Concentrates Market Revenue (US$ Mn), 2021 to 2030


Advancement in technology- improvement in preliminary diagnosis techniques to detect kidney diseases and growing penetration of preventive healthcare techniques is also a key factor anticipated to augment further the growth of the global hemodialysis concentrates market.

However, Risks and complications associated with dialysis treatment, including low blood pressure, abdominal cramps, thrombosis, sepsis, etc. is estimated to lower adoption of dialysis, thereby restricting the growth of the market. Nonetheless, with high growth in emerging economies, the government of countries such as India, China, etc. are increasing focus on rising healthcare spending. These markets are highly untapped and also lack a sturdy healthcare infrastructure. Penetration in these untapped markets by market players can result in lucrative opportunities and heightened market share for these players.

Global hemodialysis concentrates market is segmented on the basis of product type, application and region. On the basis of product type, the market is segmented into acid concentrates and bicarbonate concentrates. The acid concentrates segment accounts for the majority share and is expected to register the highest growth over the forecast period. On the basis of application, the market is segmented into dialysis center and home. The dialysis center segment accounts for a majority share in the global hemodialysis concentrates market


Global Hemodialysis Concentrates Market by Formulation, 2018


Based on region, the market is segmented into North America, Europe, APAC, South America and Middle East Africa. North America accounts for the majority share in the global hemodialysis concentrates market owing to Wider acceptance of hemodialysis treatment in this region. APAC is expected to register the highest growth rate after over forecast period owing to the increasing number of hospitals in this region. Regions such as Europe, South America and MEA are expected to register stable growth over the forecast period.

The research report on the global hemodialysis concentrates market includes profiles of some of the major companies such as Baxter International Inc., Nipro Corporation, Rockwell Medical, Inc., Cantel Medical Corp., Guangdong Biolight Meditech Co., Ltd.., Treet Corp. Ltd.and Sopharma AD.



Below are the active patents related to Hemodialysis Concentrates Market.


Patent Number: US20160213832A1

Dry peritoneal dialysis concentrate system

Abstract

A dry peritoneal dialysis (PD) concentrate system may be used in connection with a PD cycler. The dry PD concentrate system includes a concentrate container with at least two concentrate compartments, and at least one of the compartments contains a dry PD concentrate component. At least one of the concentrate compartments has a medical fluid outlet, and at least one of the concentrate compartments has a diluent inlet.

Application File Date: 2016-04-05

Application Granted Date: 2018-09-18

Current Assignee: Fresenius Medical Care Deutschland GmbH

Patent Number: US20150238680A1

Dialysis system with enhanced features

Abstract

A dialysis system includes a dialysis fluid cassette-based membrane blood pump; a dialyzer in fluid communication with the blood pump; first and second dialysis fluid cassette-based balance chambers each having (i) a fresh dialysis fluid compartment in fluid communication with the dialyzer and (ii) a spent dialysis fluid compartment; a dialysis fluid cassette-based fresh dialysis fluid membrane pump in fluid communication with the fresh dialysis fluid compartments of the first and second balance chambers; a dialysis fluid cassette-based spent dialysis fluid membrane pump in fluid communication with the dialyzer and the spent dialysis fluid compartments of the first and second balance chambers; and arterial and venous lines in fluid communication with the dialyzer for patient connection, the arterial and venous lines each including a contact used for electrically detecting a patient access disconnection.

Application File Date: 2015-05-13

Application Granted Date: 2017-01-24

Current Assignee: Baxter Healthcare SA , Baxter International Inc

Patent Number: US8685251B2

Ultra-pasteurization for dialysis machines

Abstract

Disclosed herein are water purification and supply systems for medical devices and methods of using. In an embodiment, the system includes a dialysis system including a filtration system capable of filtering a water stream, a water purification system capable of purifying the water stream in a non-batch process, a mixing system capable of producing a stream of dialysate from mixing one or more dialysate components with the water stream in a non-batch process, and a dialyzer system. The dialyzer may be a microfluidic dialyzer capable of being fluidly coupled to the stream of dialysate and a blood stream. The water purification system includes an RO filter 6122, a proportioning valve 6165, a heater 6150, first and second heat exchangers, and a throttle valve 6160.

Application File Date: 2010-12-03

Application Granted Date: 2014-04-01

Current Assignee: 
OUTSET MEDICAL Inc


Key Market Segments

By Type

  
Acid Concentrates
  
Bicarbonate Concentrates

By Application

  
Dialysis Center
  
Home


Key Market Players included in the report:


  
Asahi Kasei Corporation (Japan)
  
B. Braun Melsungen AG (Germany).
  
Baxter International Inc. (US)
  
Becton
  
Cantel Medical Corporation (US)
  
DaVita Healthcare Partners Inc. (US)
  
Dialife Group (Switzerland)
  
Diaverum Healthcare Partners (Germany)
  
Dickinson and Company (US)
  
Farmasol
  
Fresenius Medical Care Australia Pty Ltd.
  
Guangdong Biolight Meditech Co. Ltd.
  
Healthcare Partners Inc.
  
Hemoclean
  
Ion Nipro Corporation (Japan)
  
Isopure Corp. (US)
  
KGaA (Germany)
  
Mar Cor Purification Inc
  
Medites Pharma
  
Medtronic Plc (Ireland)
  
NIKKISO CO.LTD (Japan)
  
Nipro Renal Solutions
  
Rockwell Medical Inc. (US)
  
Sopharma AD
  
spol. s.r.o.
  
Treet Corp. Ltd.